Results 31 to 40 of about 37,459 (257)

Aspergillus-Specific IgG Antibodies are Associated With Fungal-Related Complications and Chronic Lung Allograft Dysfunction After Lung Transplantation. [PDF]

Transpl Int, 2023
Fungal exposure and sensitization negatively affect outcomes in various respiratory diseases, however, the effect of fungal sensitization in lung transplant (LTx) recipients is still unknown.
Beeckmans H, Van Roy E, Kaes J, Sacreas A, Geudens V, Vermaut A, Willems L, Jin X, Bos S, Vanstapel A, Van Slambrouck J, Orlitova M, Vanaudenaerde B, Ceulemans LJ, Van Raemdonck D, Neyrinck AP, Godinas L, Dupont LJ, Verleden GM, Vos R.   +19 more
europepmc   +2 more sources

Current perspectives on antibody-mediated rejection after lung transplantation [PDF]

Transplant Research and Risk Management, 2014
Chad A Witt, Ramsey R Hachem Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, Saint Louis, MO, USA Abstract: The role of donor-specific antibodies (DSA) to human leukocyte ...
Witt CA, Hachem RR
doaj   +3 more sources

Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction. [PDF]

Lung, 2022
Cytomegalovirus (CMV) is the major and most common opportunistic infection complicating lung transplant (LTX). The aim of this study was to analyse the epidemiological aspects of CMV infection in lung transplant patients subject to a pre-emptive anti-CMV
Bennett D, Bergantini L, Ferrara P, Cusi MG, Scolletta S, Montagnani F, Paladini P, Sestini P, Refini RM, Luzzi L, Fossi A, Bargagli E.   +11 more
europepmc   +2 more sources

Diagnostic value of circulating microRNA-21 in chronic lung allograft dysfunction after bilateral cadaveric and living-donor lobar lung transplantation. [PDF]

Heliyon, 2023
Background MicroRNAs (miRNAs) involved in the pathogenesis of pulmonary fibrosis have been shown to be associated with the development of chronic lung allograft dysfunction (CLAD) after lung transplantation (LT).
Shiotani T, Sugimoto S, Tomioka Y, Yamamoto H, Tanaka S, Miyoshi K, Suzawa K, Shien K, Yamamoto H, Okazaki M, Toyooka S.   +10 more
europepmc   +2 more sources

Radiological distribution patterns in restrictive chronic lung allograft dysfunction: Impact on survival across all phenotypes [PDF]

JHLT Open
Background: Restrictive chronic lung allograft dysfunction (CLAD) demonstrates poor outcomes after lung transplantation. However, the impact of radiological patterns on survival within a restrictive CLAD under the new International Society for Heart and ...
Taiki Fukuda, MD, PhD, Yusei Nakamura, MD, Shu-Chi Tseng, MD, Yuki Ko, MD, PhD, Staci M. Gagne, MD, Takeshi Johkoh, MD, PhD, Yi Li, PhD, David C. Christiani, MD, MPH, MS, Hiroya Ojiri, MD, PhD, Lynette Sholl, MD, Mizuki Nishino, MD, MPH, Hiroto Hatabu, MD, PhD   +11 more
doaj   +2 more sources

Outcomes Following ATG Therapy for Chronic Lung Allograft Dysfunction

Transplantation Direct, 2021
Background. Chronic lung allograft dysfunction (CLAD) is the major factor limiting survival post lung transplantation (LTx) with limited effective therapeutic options.
Sakhee Kotecha, FRACP, Eldho Paul, BS, MS, Steve Ivulich, MPharm, Jeremy Fuller, BS, Miranda Paraskeva, FRACP, Bronwyn Levvey, RN, Gregory Snell, MD, FRACP, Glen Westall, PhD, FRACP   +7 more
doaj   +4 more sources

Lung retransplantation for chronic lung allograft dysfunction

Polish Journal of Thoracic and Cardiovascular Surgery, 2019
Monika Kosiorowska, Bartosz Kubisa, Mikołaj Górski, Maria Piotrowska, Michał Kubisa, Mirosław Brykczyński, Małgorzata Wojtyś, Jarosław Pieróg, Michalina Czarnecka, Janusz Wójcik, Norbert Wójcik, Michał Bielewicz, Piotr Sielicki, Tomasz Grodzki   +13 more
doaj   +4 more sources

Short airway telomeres are associated with primary graft dysfunction and chronic lung allograft dysfunction. [PDF]

J Heart Lung Transplant, 2023
Greenland JR, Guo R, Lee S, Tran L, Kapse B, Kukreja J, Hays SR, Golden JA, Calabrese DR, Singer JP, Wolters PJ.   +10 more
europepmc   +3 more sources

BAL Fluid Eosinophilia Associates With Chronic Lung Allograft Dysfunction Risk: A Multicenter Study. [PDF]

Chest, 2023
Todd JL, Weber JM, Kelly FL, Neely ML, Mulder H, Frankel CW, Nagler A, McCrae C, Newbold P, Kreindler J, Palmer SM.   +10 more
europepmc   +3 more sources

Characterization of chronic lung allograft dysfunction phenotypes using spectral and intrabreath oscillometry. [PDF]

Front Physiol, 2022
Fu A, Vasileva A, Hanafi N, Belousova N, Wu J, Rajyam SS, Ryan CM, Hantos Z, Chow CW.   +8 more
europepmc   +3 more sources